Maaroufi A 1 , Vince A 2 , Himatt SM 3 , Mohamed R 4 , Fung J 5 , Opare-Sem O 6 Show all authors , Workneh A 7 , Njouom R 8 , Al Ghazzawi I 9 , Abdulla M 10 , Kaliaskarova KS 11 , Owusu-Ofori S 12 , Abdelmageed MK 13 , Adda D 14 , Akin O 15 , Al Baqali A 16 , Al Dweik N 17 , Al Ejji K 17 , Al Kaabi S 17 , Al Naamani K 18 , Al Qamish J 19 , Al Sadadi M 10 , Al Salman J 10 , AlBadri M 17 , Al-Busafi SA 20 , Al-Romaihi HE 3 , Ampofo W 21 , Antonov K 22 , Anyaike C 15 , Arome F 23 , Bane A 24 , Blach S 25 , Borodo MM 26 , Brandon SM 25 , Bright B 27 , Butt MT 17 , Cardenas I 28 , Chan HLY 29 , Chen CJ 30 , Chen DS 31 , Chen PJ 32 , Chien RN 33 , Chuang WL 34 , Cuellar D 35 , Derbala M 17 , Elbardiny AA 3 , Estes C 25 , Farag E 3 , Gamkrelidze I 25 , Garcia V 36 , Genov J 37 , Ghandour Z 38 , Ghuloom M 10 , Gomez B 39 , Gunter J 25 , Habeeb J 10 , Hajelssedig O 17 , Hamoudi W 40 , Hrstic I 41 , Hu CC 33 , Huang CF 34 , Hui YT 42 , Jahis R 43 , Jelev D 22 , John AK 17 , Kamel Y 17 , Kao JH 44 , Khamis J 10 , Khattabi H 45 , Khoudri I 1 , Konysbekova A 46 , Kotzev I 47 , Lai MS 48 , Lao WC 49 , Layden J 50 , Lee MH 51 , Lesi O 52 , Li M 53 , Lo A 54 , Loo CK 55 , Lukšić B 56 , Malu AO 57 , Mateva L 22 , Mitova R 37 , Morović M 58 , Murphy K 25 , Mustapha B 59 , Nde H 25 , Nersesov A 60 , Ngige E 15 , Njoya O 61 , Nonković D 62 , Obekpa S 23 , Oguche S 63 , Okolo EE 64 , Omede O 15 , Omuemu C 65 , Ondoa P 66 , Phillips RO 6 , Prokopenko YN 67 , Razavi H 25 , Razavi-Shearer D 25 , Redae B 68 , Reic T 69 , Rinke de Wit T 70 , Rios C 71 , Robbins S 25 , Roberts LR 72 , Sanad SJ 38 , Schmelzer JD 25 , Sharma M 17 , Simonova M 73 , Su TH 44 , Sultan K 17 , Tan SS 74 , Tchernev K 75 , Tsang OTY 76 , Tsang S 77 , Tzeuton C 78 , Ugoeze S 79 , Uzochukwu B 80 , Vi R 67 , Wani HU 17 , Wong VWS 29 , Yacoub R 17 , Yesmembetov KI 81 , Youbi M 1 , Yuen MF 82 , Razavi-Shearer K 25

Affiliations 

  • 1 National Institute of Health Administration, Rabat, Morocco
  • 2 Medical School University of Zagreb, University Hospital of Infectious Diseases Zagreb, Zagreb, Croatia
  • 3 Ministry of Public Health Qatar, Doha, Qatar
  • 4 University of Malaya Medical Centre, Kuala Lumpur, Malaysia
  • 5 Department of Medicine, The University of Hong Kong, Hong Kong, SAR, China
  • 6 Kwame Nkrumah University of Science and Technology, Kumasi, Ghana
  • 7 Non-Communicable Diseases Programme, World Health Organization, Addis Ababa, Ethiopia
  • 8 Virology Department, Centre Pasteur of Cameroon, Yaounde, Cameroon
  • 9 GI and Hepatology Department, Jordan Royal Medical Services, Amman, Jordan
  • 10 Salmaniya Medical Complex, Manama, Bahrain
  • 11 Ministry of Healthcare and Social Development of the Republic of Kazakhstan, Astana, Kazakhstan
  • 12 Komfo Anokye Teaching Hospital, Kumasi, Ghana
  • 13 Hamad Medical Corporation, Doha, Qatar
  • 14 Civil Society Network on Hepatitis, Abuja, Nigeria
  • 15 Federal Ministry of Health, Abuja, Nigeria
  • 16 Al Kindi Specialised Hospital, Manama, Bahrain
  • 17 Division of Gastroenterology, Department of Medicine, Hamad Medical Corporation, Doha, Qatar
  • 18 Division of Gastroenterology and Hepatology, Department of Medicine, Armed Forces Hospital, Muscat, Oman
  • 19 Gastroenterolgy Clinic, IBN Al-Nafees Hospital, Manama, Bahrain
  • 20 Division of Gastroenterology, Department of Medicine, Sultan Qaboos University Hospital, Muscat, Oman
  • 21 Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana
  • 22 University Hospital "St. Ivan Rilski", Sofia, Bulgaria
  • 23 Advocacy for the Prevention of Hepatitis in Nigeria, Jos, Nigeria
  • 24 Gastroenterology and Hepatology, Addis Ababa University Medical School, Addis Ababa, Ethiopia
  • 25 Center for Disease Analysis (CDA), Lafayette, CO, USA
  • 26 Aminu Kano Teaching Hospital, Kano, Nigeria
  • 27 LiveWell Initiative (LWI), Lagos, Nigeria
  • 28 Communicable Diseases Division, Ministry of Health and Social Protection, Bogota, Colombia
  • 29 Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, SAR, China
  • 30 Academia Sinica, Taipei, Taiwan
  • 31 Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan
  • 32 National Taiwan University, Taipei, Taiwan
  • 33 Liver Research Unit, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan
  • 34 Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung City, Taiwan
  • 35 Department of Epidemiology and Demography, Ministry of Health and Social Protection, Bogota, Colombia
  • 36 Ministry of Public Health, Santo Domingo, Dominican Republic
  • 37 University Hospital "Queen Joanna", Sofia, Bulgaria
  • 38 BDF Hospital, Royal Medical Services, Riffa, Bahrain
  • 39 Pan American Health Organization, Washington, DC, USA
  • 40 Department of Gastroenterology & Hepatology, Al Bashir Hospital, Amman, Jordan
  • 41 General Hospital Pula, Pula, Croatia
  • 42 Department of Medicine, Queen Elizabeth Hospital, Hong Kong, SAR, China
  • 43 Disease Control Division, Ministry of Health, Putrajaya, Malaysia
  • 44 Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan
  • 45 Eastern Mediterranean Regional Office, World Health Organization, Cairo, Egypt
  • 46 Republican Diagnostic Center, Astana, Kazakhstan
  • 47 University Hospital "St. Marina", Varna, Bulgaria
  • 48 Department of Medicine, North District Hospital, Hong Kong, SAR, China
  • 49 Department of Medicine, Pamela Youde Nethersole Eastern Hospital, Hong Kong, SAR, China
  • 50 Department of Public Health Sciences, Loyola University Chicago, Chicago, IL, USA
  • 51 Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan
  • 52 University of Lagos, Lagos, Nigeria
  • 53 Division of Gastroenterology and Hepatology, Department of Medicine and Geriatrics, Tuen Mun Hospital, Hong Kong, SAR, China
  • 54 Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, SAR, China
  • 55 Department of Medicine and Geriatrics, Kwong Wah Hospital, Hong Kong, SAR, China
  • 56 Clinical Department of Infectious Diseases, Split University Hospital and Split University Medical School, Split, Croatia
  • 57 Benue State University Teaching Hospital, Makurdi, Nigeria
  • 58 Department of Infectious Diseases, Zadar General Hospital, Zadar, Croatia
  • 59 IBN SINA Hospital, Rabat, Morocco
  • 60 National Research Institute of Cardiology and Internal Diseases, Almaty, Kazakhstan
  • 61 Research Laboratory on Viral Hepatitis & Health Communication, Faculty of Medicine, University of Yaoundé, Yaoundé, Cameroon
  • 62 Department of Epidemiology, Institute of Public Health, County of Dalmatia, Split, Croatia
  • 63 Department of Pediatrics, University of Jos, Jos, Nigeria
  • 64 Beacon Youth Initiative, Lafia, Nigeria
  • 65 University of Benin, Benin City, Nigeria
  • 66 Amsterdam Institute for Global Health and Development, Amsterdam, Netherlands
  • 67 Republican Coordination Center for Hepatology and Gastroenterology, Astana, Kazakhstan
  • 68 Ethiopian Gastroenterological Association, Addis Ababa, Ethiopia
  • 69 European Liver Patients Association, Sint-Truiden, Belgium
  • 70 PharmAccess Foundation, Department of Global Health, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
  • 71 Department of Health Promotion and Disease Prevention, Ministry of Health and Social Protection, Bogota, Colombia
  • 72 Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA
  • 73 Clinic of Gastroenterology, Military Medical Academy, Sofia, Bulgaria
  • 74 Department of Hepatology, Selayang Hospital, Selangor, Malaysia
  • 75 "Sofiamed" Hospital, Sofia, Bulgaria
  • 76 Department of Medicine and Geriatrics, Princess Margaret Hospital Authority, Hong Kong, SAR, China
  • 77 Department of Medicine, Tseung Kwan O Hospital, Hong Kong, SAR, China
  • 78 Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon
  • 79 Federal Medical Centre, Jalingo, Nigeria
  • 80 Institute of Public Health, University of Nigeria, Nsukka, Nigeria
  • 81 National Scientific Center of Oncology and Transplantology, Astana, Kazakhstan
  • 82 Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, SAR, China
J. Viral Hepat., 2017 10;24 Suppl 2:8-24.
PMID: 29105285 DOI: 10.1111/jvh.12762

Abstract

Due to the introduction of newer, more efficacious treatment options, there is a pressing need for policy makers and public health officials to develop or adapt national hepatitis C virus (HCV) control strategies to the changing epidemiological landscape. To do so, detailed, country-specific data are needed to characterize the burden of chronic HCV infection. In this study of 17 countries, a literature review of published and unpublished data on HCV prevalence, viraemia, genotype, age and gender distribution, liver transplants and diagnosis and treatment rates was conducted, and inputs were validated by expert consensus in each country. Viraemic prevalence in this study ranged from 0.2% in Hong Kong to 2.4% in Taiwan, while the largest viraemic populations were in Nigeria (2 597 000 cases) and Taiwan (569 000 cases). Diagnosis, treatment and liver transplant rates varied widely across the countries included in this analysis, as did the availability of reliable data. Addressing data gaps will be critical for the development of future strategies to manage and minimize the disease burden of hepatitis C.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.